Craig L Slingluff Selected Research

Drug Therapy (Chemotherapy)

1/2022

Peptide emulsions in incomplete Freund's adjuvant create effective nurseries promoting egress of systemic CD4+ and CD8+ T cells for immunotherapy of cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Craig L Slingluff Research Topics

Disease

122	Melanoma (Melanoma, Malignant) 03/2024 - 01/2002
90	Neoplasms (Cancer) 04/2024 - 01/2002
24	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2004
10	Tetanus 01/2022 - 11/2003
8	Testicular Neoplasms (Testicular Cancer) 01/2021 - 01/2004
7	Tertiary Lymphoid Structures 01/2023 - 01/2018
5	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 01/2016
4	Injection Site Reaction 01/2022 - 09/2004
4	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2005
3	Lymphatic Metastasis 01/2023 - 03/2016
3	Ovarian Neoplasms (Ovarian Cancer) 11/2021 - 05/2008
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 02/2004
2	Adenocarcinoma 12/2023 - 01/2018
2	Anemia 01/2022 - 09/2004
2	Exanthema (Rash) 01/2022 - 01/2021
2	Fatigue 01/2022 - 05/2008
1	Pruritus (Itching) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Fever (Fevers) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022

Drug/Important Bio-Agent (IBA)

58	VaccinesIBA 03/2024 - 01/2002
54	Peptides (Polypeptides)IBA 03/2024 - 01/2002
29	AntigensIBA 04/2024 - 01/2004
19	Protein Subunit VaccinesIBA 01/2022 - 09/2004
18	Proteins (Proteins, Gene)FDA Link 03/2024 - 03/2003
15	incomplete Freund's adjuvantIBA 01/2022 - 11/2009
12	Cancer VaccinesIBA 04/2024 - 04/2005
10	CytokinesIBA 01/2020 - 01/2002
9	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022 - 11/2003
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2005
8	AntibodiesIBA 08/2021 - 01/2002
8	EpitopesIBA 11/2014 - 03/2003
7	LigandsIBA 01/2023 - 08/2011
7	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2016
7	Interleukin-2 (IL2)IBA 12/2011 - 09/2004
6	InterferonsIBA 01/2023 - 01/2002
6	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2002
6	Monatide (IMS 3015)IBA 01/2022 - 11/2003
5	IpilimumabIBA 01/2021 - 01/2016
5	Toll-Like Receptor AgonistsIBA 01/2021 - 09/2011
5	Monophenol Monooxygenase (Tyrosinase)IBA 01/2021 - 11/2003
5	ChemokinesIBA 10/2016 - 11/2010
5	HLA-A2 Antigen (HLA A2 Antigen)IBA 05/2008 - 11/2003
4	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 03/2024 - 05/2008
4	Imiquimod (Aldara)FDA LinkGeneric 01/2023 - 01/2010
4	NivolumabIBA 10/2020 - 01/2016
4	HLA-A3 Antigen (HLA A3 Antigen)IBA 05/2008 - 11/2003
4	HLA Antigens (Human Leukocyte Antigens)IBA 05/2008 - 11/2004
3	pembrolizumabIBA 12/2023 - 12/2022
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2002
3	EmulsionsIBA 01/2022 - 11/2003
3	PhosphopeptidesIBA 11/2021 - 12/2014
3	poly ICLCIBA 01/2021 - 11/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019 - 06/2008
3	Phosphotransferases (Kinase)IBA 01/2015 - 10/2005
3	Bevacizumab (Avastin)FDA Link 09/2013 - 06/2008
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2011 - 06/2008
2	Complementary DNA (cDNA)IBA 03/2024 - 03/2003
2	Immunoconjugates (Immunoconjugate)IBA 03/2024 - 02/2018
2	Toll-Like Receptor 7IBA 01/2023 - 01/2021
2	Colloids (Colloid)IBA 01/2023 - 11/2002
2	SulfurIBA 01/2023 - 11/2002
2	CateninsIBA 08/2021 - 07/2019
2	IntegrinsIBA 01/2021 - 02/2014
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 09/2015
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 07/2011
2	CollagenIBA 01/2021 - 08/2004
2	ParaffinIBA 10/2020 - 09/2014
2	Filaggrin ProteinsIBA 10/2019 - 01/2016
2	EnzymesIBA 01/2019 - 08/2016
2	Monoclonal AntibodiesIBA 02/2018 - 04/2005
2	Interferon-gamma (Interferon, gamma)IBA 10/2016 - 09/2015
2	Proto-Oncogene Proteins B-rafIBA 08/2016 - 10/2005
2	PLX 4720IBA 08/2016 - 01/2015
2	Chemokine ReceptorsIBA 03/2016 - 11/2013
2	Melanoma-Specific AntigensIBA 09/2015 - 04/2006
2	Mitogen-Activated Protein KinasesIBA 01/2015 - 08/2004
2	tyrosine receptor (receptor, tyrosine)IBA 01/2015 - 08/2011
2	temsirolimus FDA Link 09/2013 - 07/2013
2	Protein Kinases (Protein Kinase)IBA 07/2013 - 10/2005
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2011 - 06/2008
2	Small Interfering RNA (siRNA)IBA 12/2011 - 06/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2011 - 08/2011
2	Sirolimus (Rapamycin)FDA Link 06/2008 - 10/2005
2	gp100(280-288) melanoma antigen peptideIBA 11/2004 - 11/2004
1	Chimeric Antigen ReceptorsIBA 03/2024
1	NF-kappa B (NF-kB)IBA 09/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Carcinoembryonic AntigenIBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Liposomes (Liposome)IBA 01/2022

Therapy/Procedure

49	Therapeutics 03/2024 - 09/2004
29	Immunotherapy 12/2023 - 01/2002
7	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 11/2002
3	Neoadjuvant Therapy 12/2023 - 01/2023
3	Biological Therapy 05/2011 - 12/2008
2	Gamma Cameras (Gamma Camera) 01/2023 - 04/2011
2	Metastasectomy 01/2021 - 01/2021
2	Immunomodulation 01/2018 - 05/2008
1	Drug Therapy (Chemotherapy) 01/2022